Cargando…
Olanzapine induced de-novo obsessive compulsive disorder in a patient with schizophrenia
There are reports of de novo development or exacerbation of obsessive-compulsive symptoms in patients with schizophrenia treated with atypical antipsychotics, although this is widely debated. We report one such case where a patient with a primary diagnosis of schizophrenia, treated with olanzapine,...
Autores principales: | Kulkarni, Gajanan, Narayanaswamy, Janardhanan C., Math, Suresh Bada |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480803/ https://www.ncbi.nlm.nih.gov/pubmed/23112432 http://dx.doi.org/10.4103/0253-7613.100406 |
Ejemplares similares
-
Fluvoxamine induced oculogyric dystonia and manic switch in a patient with obsessive compulsive disorder
por: Tikka, Sai Krishna, et al.
Publicado: (2013) -
A suspected case of olanzapine induced hyponatremia
por: Bakhla, Ajay Kumar, et al.
Publicado: (2014) -
Clinical practice guidelines for Obsessive-Compulsive Disorder
por: Janardhan Reddy, Y.C., et al.
Publicado: (2017) -
Olanzapine-induced restless leg syndrome: A case report and review of literature
por: Basu, Aniruddha, et al.
Publicado: (2014) -
Reversible bilateral sensori-neural hearing loss due to olanzapine in a male suffering from bipolar affective disorder
por: Gupta, Sumit Kumar, et al.
Publicado: (2014)